Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
MIND Technology
MIND
$43.1M
| $219K | ﹤0.01% |
47,700
-550
| -1% | -$2.93K |
|
|
TIGR
3377
UP Fintech Holding
TIGR
$822M
| $219K | ﹤0.01% |
64,300
+31,300
| +95% | +$135K |
|
|
NCNA
3378
NuCana
NCNA
$6.45M
| $218K | ﹤0.01% |
66
-4
| -6% | -$18.4K |
|
|
CALA
3379
DELISTED
Calithera Biosciences, Inc
CALA
| $218K | ﹤0.01% |
66,795
-47,760
| -42% | -$114K |
|
3380
iShares Europe ETF
IEV
$1.7B
| $217K | ﹤0.01% |
4,800
-1,800
| -27% | -$77.5K |
|
3381
Myriad Genetics
MYGN
$299M
| $217K | ﹤0.01% |
14,974
-154,800
| -91% | -$2.88M |
|
3382
InflaRx
IFRX
$286M
| $215K | ﹤0.01% |
69,300
-17,802
| -20% | -$45.3K |
|
3383
Q2 Holdings
QTWO
$4.04B
| $215K | ﹤0.01% |
8,000
-17,000
| -68% | -$475K |
|
3384
iShares Select U.S. REIT ETF
ICF
$2.12B
| $214K | ﹤0.01% |
3,900
-7,700
| -66% | -$421K |
|
3385
Superior Group of Companies
SGC
$207M
| $214K | ﹤0.01% |
+21,275
| New | +$205K |
|
|
TRVG
3386
trivago
TRVG
$363M
| $214K | ﹤0.01% |
31,740
-17,493
| -36% | -$107K |
|
3387
Enlivex Ltd
ENLV
$27.1M
| $213K | ﹤0.01% |
3,613
-313
| -8% | -$20.2K |
|
3388
Hagerty
HGTY
$1.32B
| $213K | ﹤0.01% |
+25,300
| New | +$220K |
|
3389
Ribbon Communications
RBBN
$376M
| $213K | ﹤0.01% |
76,200
-207,924
| -73% | -$539K |
|
3390
-1x Short VIX Futures ETF
SVIX
$171M
| $213K | ﹤0.01% |
14,500
-98,600
| -87% | -$1.25M |
|
|
WMC
3391
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $212K | ﹤0.01% |
23,310
+400
| +2% | +$3.77K |
|
3392
Sabra Healthcare REIT
SBRA
$5.13B
| $211K | ﹤0.01% |
+17,000
| New | +$217K |
|
|
FNCB
3393
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $211K | ﹤0.01% |
25,656
+2,456
| +11% | +$19.4K |
|
|
TAST
3394
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $211K | ﹤0.01% |
155,500
+600
| +0.4% | +$935 |
|
3395
EVI Industries
EVI
$215M
| $210K | ﹤0.01% |
+8,797
| New | +$173K |
|
3396
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.17B
| $210K | ﹤0.01% |
7,300
-2,400
| -25% | -$66.3K |
|
3397
Richmond Mutual Bancorp
RMBI
$258M
| $210K | ﹤0.01% |
16,142
-2,200
| -12% | -$28.8K |
|
3398
Fox Factory Holding Corp
FOXF
$887M
| $209K | ﹤0.01% |
2,293
-88,500
| -97% | -$8.23M |
|
3399
iShares US Technology ETF
IYW
$25.7B
| $209K | ﹤0.01% |
+2,800
| New | +$214K |
|
3400
Old National Bancorp
ONB
$10.4B
| $209K | ﹤0.01% |
+11,600
| New | +$213K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.